Diagnosis and treatment of bone marrow edema syndrome of the hip and differential diagnosis from avascular necrosis of femoral head.
- Author:
Jian-Feng LI
1
;
Jin-Yu YAN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Bone Density Conservation Agents; therapeutic use; Bone Marrow Diseases; diagnosis; drug therapy; pathology; therapy; Diphosphonates; therapeutic use; Female; Femur Head Necrosis; diagnosis; pathology; Hip Joint; drug effects; pathology; Humans; Male; Middle Aged
- From: China Journal of Orthopaedics and Traumatology 2009;22(9):697-699
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the diagnosis and treatment of bone marrow edema syndrome and summarize its features, mechanisms and its differences from avascular necrosis of femoral head.
METHODSFrom 2004.1, 19 patients (12 patients were males and 7 patients were females, with a mean age of (46.70 +/- 10.36) years) with bone marrow edema syndrome of hip treated with Ibandronate and physical therapy, as well as scored with Harris system before and after treatment.
RESULTSAverage score before treatment was (43.17 +/- 12.62), and (86.73 +/- 14.29) after treatment, and the difference was significant (P < 0.05).
CONCLUSIONBone marrow edema syndrome of hip is different from avascular necrosis of the hip, it is a distinct clinical entity.
